Amalgamated Financial’s Ironwood Pharmaceuticals IRWD Stock Holding History

Amalgamated Financial’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$301K	Buy	+23,936	New	+$274K	﹤0.01%	1736

Other funds holding IRWD

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Amalgamated Financial's IRWD Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Ironwood Pharmaceuticals (IRWD) in Q1 2022: 23,936 shares worth $301K. The stake represents ﹤0.01% of the portfolio and ranks #1736 among its holdings.

221 funds tracked by Wall St. Rank hold IRWD as of Q1 2022.

Amalgamated Financial held 23,936 shares of Ironwood Pharmaceuticals worth $301K as of Q1 2022.
Ironwood Pharmaceuticals was a new Amalgamated Financial position in Q1 2022.
Ironwood Pharmaceuticals made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #1736 holding.
221 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.